NovoCure (N2VC34.SA) Q2 2026 Earnings

Apr 30Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-3.08
-2.64
-2.2
-1.76

Details

Expected EPS
-2.5451546712
Actual EPS
-3.080904
Surprise EPS
-0.54
Surprise Percent
-21.05%

Description

⁨NovoCure⁩ (⁦N2VC34.SA⁩) has reported earnings of ⁦-3.080904⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts